The Pictet Group

The Pictet Group is a Swiss private bank and investment-led service company, founded in 1805. The firm provides wealth management for wealthy individuals and families, asset management for professional investors and their clients, asset services for fund managers, external asset managers and institutions, and alternative investments for institutional and private investors. Pictet does not engage in investment banking or extend commercial loans. The firm's stated purpose is "to build responsible partnerships with our clients, colleagues and the companies in which we invest, in order to safeguard and transmit wealth, of all kinds, in the service of the real economy." In September 2021, Pictet Group had $746 billion (EUR 644 billion) in assets under management or custody.

The Pictet Group is headquartered in Geneva, Switzerland, with offices in Basel, Lausanne, Zurich, Amsterdam, Barcelona, Brussels, Frankfurt, London, Luxembourg, Madrid, Milan, Monaco, Munich, Paris, Rome, Stuttgart, Turin, Verona, Hong Kong, Osaka, Shanghai, Singapore, Taipei, Tokyo, Dubai, Tel Aviv, Montreal, Nassau, and New York. The Pictet Group is structured as a partnership of eight owner-managers responsible for all activities of the firm. In 2021, there had been forty-five partners since the firm's founding in 1805, each with an average tenure of over twenty-one years.

Pictet Group has invested in Chainalysis, Red Date Technology, Cellarity, NetGuardians, SOPHiA GENETICS, Moderna Therapeutics, Athena Art, CymaBay Therapeutics, and NovImmune. Notable exits of Pictet include SOPHiA GENETICS, Moderna Therapeutics, and CymaBay Therapeutics.